DDB Remedy picks up Novartis OTC launch

Novartis, the pharmaceutical giant, has appointed DDB Remedy to handle the international roll-out of a new over-the-counter product.

Novartis: appoints DDB Remedy
Novartis: appoints DDB Remedy

The intermediary Hestbæk Consult handled the pitch, which began in November last year.

DDB Remedy, DDB’s health arm, will create a campaign for the product, dubbed "Project Cool", across Europe, the US and Asia. It is expected to target consumers and healthcare professionals.

The product is thought to relate to Novartis’ US high-strength pain-relief brand Excedrin. The tablet was recalled in the US last year after a series of faulty batches were distributed.

Novartis works with a number of agencies including DraftFCB London, Wunderman Switzerland and Grey Group.

Topics

SUBSCRIBE TO CAMPAIGN

Get 12 weeks for just £12

Includes weekly and quarterly print issues, plus unrestricted online access.

SUBSCRIBE

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an Alert Now

Just published